000 | 01923 a2200481 4500 | ||
---|---|---|---|
005 | 20250514011541.0 | ||
264 | 0 | _c20011101 | |
008 | 200111s 0 0 eng d | ||
022 | _a0959-8049 | ||
024 | 7 |
_a10.1016/s0959-8049(01)00156-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTimoshenko, A V | |
245 | 0 | 0 |
_aImmunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. _h[electronic resource] |
260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cOct 2001 |
||
300 |
_a1910-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xblood supply |
650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCapillary Permeability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
650 | 0 | 4 |
_aKidney _xmetabolism |
650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xblood supply |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 | _aPlant Preparations |
650 | 0 | 4 | _aPlant Proteins |
650 | 0 | 4 |
_aPleural Effusion, Malignant _xmetabolism |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 | _aRibosome Inactivating Proteins, Type 2 |
650 | 0 | 4 |
_aToxins, Biological _xtherapeutic use |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
700 | 1 | _aLan, Y | |
700 | 1 | _aGabius, H J | |
700 | 1 | _aLala, P K | |
773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 37 _gno. 15 _gp. 1910-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(01)00156-3 _zAvailable from publisher's website |
999 |
_c11498455 _d11498455 |